Squarepoint Ops LLC Wave Life Sciences Ltd. Transaction History

Squarepoint Ops LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $120,887 - $233,579	34,149 New	34,149 $210,000
Q2 2023 Aug 14, 2023	BUY	$3.51 - $4.69 $331,712 - $443,228	94,505 Added 498.13%	113,477 $413,000
Q1 2023 May 15, 2023	BUY	$3.58 - $6.3 $67,919 - $119,523	18,972 New	18,972 $82,000
Q4 2021 Feb 14, 2022	SELL	$3.14 - $5.15 $63,051 - $103,412	-20,080 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.89 - $7.12 $70,636 - $102,848	-14,445 Reduced 41.84%	20,080 $98,000
Q2 2021 Aug 16, 2021	SELL	$5.65 - $7.47 $196,320 - $259,560	-34,747 Reduced 50.16%	34,525 $230,000
Q1 2021 May 17, 2021	SELL	$5.61 - $12.01 $403,078 - $862,918	-71,850 Reduced 50.91%	69,272 $389,000
Q4 2020 Feb 16, 2021	BUY	$6.99 - $9.26 $326,139 - $432,053	46,658 Added 49.39%	141,122 $1.11 Million
Q3 2020 Nov 16, 2020	BUY	$8.49 - $19.54 $801,999 - $1.85 Million	94,464 New	94,464 $802,000
Q1 2020 May 15, 2020	SELL	$6.94 - $14.22 $546,427 - $1.12 Million	-78,736 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.99 - $37.6 $629,100 - $2.96 Million	78,736 New	78,736 $631,000

171

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $882M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.